A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden.
Rebeck ON, Wallace MJ, Prusa J, Ning J, Evbuomwan EM, Rengarajan S, Habimana-Griffin L, Kwak S, Zahrah D, Tung J, Liao J, Mahmud B, Fishbein SRS, Ramirez Tovar ES, Mehta R, Wang B, Gorelik MG, Helmink BA, Dantas G.
Rebeck ON, et al. Among authors: fishbein srs.
Cell Chem Biol. 2024 Nov 16:S2451-9456(24)00452-5. doi: 10.1016/j.chembiol.2024.10.013. Online ahead of print.
Cell Chem Biol. 2024.
PMID: 39571582
Free article.